Effects of SGLT-2 Inhibitor on Glucose and Lipid Metabolism and Carotid Artery Remodeling in T2DM Patients with Hypertension

Effects of SGLT-2 Inhibitor on Glucose and Lipid Metabolism and Carotid Artery Remodeling in T2DM Patients with Hypertension

PANG Yaping, JIANG Lanye, LI Xiufen, FENG Jinfeng

PDF(999 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(999 KB)

Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (9) : 1536-1541. DOI: 10.11748/bjmy.issn.1006-1703.2022.09.022

Clinical Investigation

Effects of SGLT-2 Inhibitor on Glucose and Lipid Metabolism and Carotid Artery Remodeling in T2DM Patients with Hypertension

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(9): 1536-1541 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.09.022

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(999 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉